2009
DOI: 10.1051/medsci/200925124
|View full text |Cite
|
Sign up to set email alerts
|

Un nouvel espoir dans le traitement de la schistosomiase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…For the past thirty years, the most widely used drug has been Praziquantel (PZQ) because it has many advantages. In addition to being effective against all species of schistosomes with very few side effects, this drug can be administered orally in a single dose and is inexpensive (Dissous et al, 2009). However, evidence of emerging drug resistance and low efficacy of PZQ has been reported in Egypt and Senegal (Cioli et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…For the past thirty years, the most widely used drug has been Praziquantel (PZQ) because it has many advantages. In addition to being effective against all species of schistosomes with very few side effects, this drug can be administered orally in a single dose and is inexpensive (Dissous et al, 2009). However, evidence of emerging drug resistance and low efficacy of PZQ has been reported in Egypt and Senegal (Cioli et al, 2008).…”
Section: Introductionmentioning
confidence: 99%